Phase II Study Of Decitabine In Patients With Metastatic Papillary Thyroid Cancer Or Follicular Thyroid Cancer Unresponsive To Radioiodine.
Phase of Trial: Phase II
Latest Information Update: 03 Dec 2018
At a glance
- Drugs Decitabine (Primary) ; Fludeoxyglucose F-18; Iodine-131; Liothyronine; Thyrotropin alfa
- Indications Thyroid cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 27 Aug 2013 Planned end date changed from 1 Jan 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.
- 01 Apr 2013 Status changed from suspended to active, no longer recruiting as reported by ClinicalTrials.gov.